RESISTANT HYPERTENSION
Clinical trials for RESISTANT HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new RESISTANT HYPERTENSION trials appear
Sign up with your email to follow new studies for RESISTANT HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could tame stubborn high blood pressure
Disease control CompletedThis study tested an experimental drug called XXB750 in 189 adults with resistant hypertension—high blood pressure that stays high despite taking three or more standard medications. Participants received different doses of XXB750 or a placebo as a shot under the skin, on top of t…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:44 UTC
-
New pill may tame stubborn high blood pressure
Disease control CompletedThis study tested a new medicine called baxdrostat in 218 adults whose high blood pressure remained high despite taking three or more different blood pressure drugs. The goal was to see if baxdrostat could lower blood pressure more than a placebo over 12 weeks. Participants took …
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New pill could help when blood pressure meds Aren't enough
Disease control CompletedThis study tested a new drug called baxdrostat in 326 adults whose high blood pressure remains uncontrolled despite taking two or more medications, including some with resistant hypertension. The goal was to see if adding baxdrostat lowers blood pressure more than a placebo after…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Nurse talks beat high blood pressure: education on side effects shows promise
Disease control CompletedThis study tested a nurse-led educational program for 46 adults with resistant hypertension (high blood pressure not controlled by three or more drugs). The program focused on teaching patients about common side effects like sexual problems and bladder control issues. The goal wa…
Matched conditions: RESISTANT HYPERTENSION
Phase: NA • Sponsor: Consorci Sanitari Integral • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New pill may help when blood pressure meds aren't enough
Disease control CompletedThis study tested a new drug called baxdrostat in about 800 adults with high blood pressure that remains high despite taking two or more medications. Participants took either 1 mg, 2 mg, or a placebo pill daily for 12 weeks. The goal was to see if baxdrostat could safely lower bl…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Tiny vessels, big clues: new study probes hidden damage in stubborn hypertension
Knowledge-focused CompletedThis study looked at tiny blood vessels in the skin of people with resistant hypertension (high blood pressure that doesn't respond well to multiple drugs). Researchers compared 111 participants to see if changes in these vessels could help predict heart risks. The goal was to fi…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: National Institute of Cardiology, Laranjeiras, Brazil • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC
-
Hidden hormone culprit found in many with stubborn high blood pressure
Knowledge-focused CompletedThis study looked at over 1,100 adults in the US with resistant hypertension (high blood pressure that doesn't respond well to treatment) to find out how many also have a condition called endogenous hypercortisolism, where the body makes too much cortisol. Participants provided b…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC